Published in Can Psychiatr Assoc J on June 01, 1972
Problem patients in a psychiatric inpatient setting. An explorative study. Eur Arch Psychiatry Neurol Sci (1986) 0.80
Rates of mitochondrial DNA evolution in sharks are slow compared with mammals. Nature (1992) 2.82
Skin content of 7-dehydrocholesterol in patients with malabsorption. Nutrition (1997) 1.42
Structural biology and phylogenetic estimation. Nature (1997) 1.34
Placebo-controlled double-blind trial of mianserin hydrochloride. Br J Clin Pharmacol (1978) 1.21
Plasma levels of imipramine and desmethylimipramine during therapy. Br J Psychiatry (1967) 1.21
A double-blind comparison of paroxetine and placebo in the treatment of depressed patients in a psychiatric outpatient clinic. Acta Psychiatr Scand Suppl (1989) 1.17
Why smoke fewer cigarettes? Br Med J (Clin Res Ed) (1982) 1.12
Lithium in non-manic-depressives: antiaggressive effect and red blood cell lithium values. Br J Psychiatry (1975) 1.08
A two-year double-blind crossover trial of the prophylactic effect of methylene blue in manic-depressive psychosis. Biol Psychiatry (1986) 1.08
Defective genetic control of sodium-pump density in manic depressive psychosis. Psychol Med (1981) 1.08
Erythrocyte membrane cation carrier in depressive illness. Psychol Med (1973) 1.03
Hydrophobicity and phylogeny. Nature (1995) 1.02
Sleep patterns in depressive states. Br J Med Psychol (1972) 1.01
Rapid flux in plant genomes. Nat Genet (1998) 0.99
A controlled trial of methylene blue in severe depressive illness. Biol Psychiatry (1987) 0.97
Circadian rhythms of water and electrolyte excretion in manic-depressive psychosis. Br J Psychiatry (1969) 0.95
Controlled studies of the acute antidepressant effects of lithium. Br J Psychiatry (1979) 0.90
Vitamin D intoxication, with hypernatraemia, potassium and water depletion, and mental depression. Br Med J (1968) 0.90
Short-cycle manic depressive psychosis in mental defectives: a clinical and physiological study. J Ment Defic Res (1976) 0.90
A double-blind trial of long-term lithium therapy in mental defectives. Br J Psychiatry (1974) 0.88
Erythrocyte membrane cation carrier in mania. Psychol Med (1976) 0.88
A biochemical study of short-cycle manic-depressive psychosis in mental defectives. Br J Psychiatry (1976) 0.88
Tissue vanadium levels in manic-depressive psychosis. Psychol Med (1984) 0.87
Erythrocyte membrane cation carrier, relapse rate of manic-depressive illness and response to lithium. Psychol Med (1976) 0.87
Plasma vanadium concentration in manic-depressive illness. Psychol Med (1982) 0.86
Lithium and erythrocyte membrane cation carrier studies in normal and manic depressive subjects. Psychol Med (1977) 0.86
Emotional disturbance following childbirth: clinical findings and urinary excretion of cyclic AMP (adenosine 3'5'cyclic monophosphate). Psychol Med (1979) 0.85
Elevated vanadium content of hair and mania. Biol Psychiatry (1984) 0.84
Plasma magnesium and calcium levels in depressive psychosis. Br J Psychiatry (1972) 0.84
Opiate antagonists and the modification of heroin self-administration behavior in man: an experimental study. Int J Addict (1976) 0.84
Fatality due to massive overdose of sodium valproate. Scott Med J (1987) 0.83
Attempt to demonstrate an in vivo effect of mianserin hydrochloride on erythrocyte Na+-K+-ATPase activity and cyclic AMP concentration. Br J Clin Pharmacol (1978) 0.83
Methylene blue in mania. Biol Psychiatry (1988) 0.82
Trial of digoxin in mania. Lancet (1975) 0.82
Plasma tryptophan concentration in depressive illness and mania. Br J Psychiatry (1976) 0.82
The effect of digoxin on the response to lithium therapy in mania. Psychol Med (1982) 0.81
Comparison of the prophylactic action of flupenthixol with placebo in lithium treated manic-depressive patients. Br J Psychiatry (1986) 0.81
Lithium therapy and erythrocyte membrane cation carrier. Psychopharmacologia (1974) 0.80
A behavioral paradigm for the evaluation of narcotic antagonists. Arch Gen Psychiatry (1976) 0.80
Erythrocyte membrane cation carrier in manic-depressive psychosis. Psychol Med (1980) 0.80
Methylene blue. A possible treatment for manic depressive psychosis. J Affect Disord (1983) 0.80
D-1 dopaminergic and beta-adrenergic stimulation of adenylate cyclase in a clone derived from the human astrocytoma cell line G-CCM. J Neurochem (1986) 0.80
Affective changes in chronic opiate use. Br J Addict Alcohol Other Drugs (1976) 0.79
Changes in erythrocyte sodium and potassium on recovery from a depressive illness. Br J Psychiatry (1971) 0.79
Possible explanation for therapeutic action of lithium, and a possible substitute (methylene-blue) Lancet (1981) 0.79
Analysis and modification of opiate reinforcement. Int J Addict (1976) 0.79
Plasma concentrations of protriptyline and clinical effects in depressed women. Br J Psychiatry (1976) 0.79
Lithium side effects in a routine lithium clinic. Br J Psychiatry (1979) 0.78
Psychopathology, craving, and mood during heroin acquisition: an experimental study. Int J Addict (1976) 0.78
Phylogenetic inference from conserved sites alignments. J Exp Zool (1999) 0.78
Changes in the erythrocyte sodium pump with age. Gerontology (1977) 0.77
Vanadium: a possible aetiological factor in manic depressive illness. Psychol Med (1981) 0.77
Prediction of clinical course of bipolar manic depressive illness treated with lithium. Psychol Med (1980) 0.77
A double blind placebo controlled trial of ascorbic acid in obesity. Nutr Health (1985) 0.77
Reversal of vanadate-induced inhibition of Na-K ATPase. A possible explanation of the therapeutic effect of carbamazepine in affective illness. J Affect Disord (1985) 0.77
A double-blind, placebo controlled, crossover trial of carbamazepine in overactive, severely mentally handicapped patients. Psychol Med (1981) 0.76
Unpleasant taste--a neglected symptom in depression. J Affect Disord (1989) 0.76
Erythrocyte sodium and potassium in depre- ssive illness. J Psychosom Res (1970) 0.76
Behavioral and social effects of heroin self-administration and withdrawal. Arch Gen Psychiatry (1976) 0.76
Factor VIII-related antigen and procoagulant activity in manic-depressive patients. J Affect Disord (1983) 0.76
Pharmacokinetic aspects of protriptyline plasma levels. Eur J Clin Pharmacol (1977) 0.76
Vanadium and manic depressive psychosis. Nutr Health (1984) 0.76
Cation transport in lymphoblastoid cell lines established from bipolar manic-depressive patients. J Affect Disord (1989) 0.76
The therapeutic effect of ascorbic acid and EDTA in manic-depressive psychosis: double-blind comparisons with standard treatments. Psychol Med (1984) 0.76
Drinking patterns of chronic alcoholics: gambling and motivation for alcohol. Psychiatr Res Rep Am Psychiatr Assoc (1968) 0.75
Some biochemical findings during pregnancy and after delivery in relation to mood change. Psychol Med (1982) 0.75
Breathlessness and anxiety. Br Med J (1970) 0.75
Profound hypothermia on combined lithium carbonate and diazepam treatment. Br Med J (1977) 0.75
The effect of mianserin on urinary catecholamine excretion in psychiatric patients. Br J Clin Pharmacol (1981) 0.75
Bromocriptine in mania--a placebo-controlled double-blind trial. Br Med J (1980) 0.75
Psychopathology and mood during heroin use: acute vs chronic effects. Arch Gen Psychiatry (1976) 0.75
Tyramine conjugation and antidepressants. Lancet (1989) 0.75
Trace elements in manic depressive psychosis. J Affect Disord (1985) 0.75
Alteration of pharmacokinetics after halving a slow-release theophylline tablet. Pharmatherapeutica (1983) 0.75
Indoleamine metabolism in affective disorders: excretion of tryptamine, indoleacetic acid and 5-hydroxy-indoleacetic acid in depressive states. J Psychosom Res (1972) 0.75
Reduced ouabain binding to erythrocytes in epilepsy--evidence for a membrane abnormality. Epilepsy Res (1989) 0.75
Caesium levels in manic depressive psychosis. J Affect Disord (1989) 0.75
Measurement of valproic acid in serum as the 4-bromophenacyl ester by high performance liquid chromatography. Clin Chim Acta (1983) 0.75
Methysergide in mania: a double-blind comparison with thioridazine. Psychol Med (1972) 0.75
The plasma control of erythrocyte sodium and potassium metabolism in depressive illness. J Psychosom Res (1970) 0.75
Methylene blue excretion in depression. Biol Psychiatry (1989) 0.75
Clomipramine and flupenthixol--additive antidepressants? Br J Psychiatry (1987) 0.75
Incorporation of inositol into the phosphoinositides of lymphoblastoid cell lines established from bipolar manic-depressive patients. J Affect Disord (1990) 0.75
Serum thiocyanate levels in subjects who halve their cigarette consumption. J Cardiovasc Surg (Torino) (1985) 0.75
A simple method for the determination of protriptyline in plasma. Clin Chim Acta (1973) 0.75
Conflicting phylogenetic patterns caused by molecular mechanisms in mitochondrial DNA sequences. Syst Biol (1998) 0.75
Whole blood adenosine triphosphate in manic-depressive illness. Br J Psychiatry (1976) 0.75
A double-blind out-patient trial of indalpine vs mianserin. Br J Psychiatry (1985) 0.75